Could immune cells from your own body help you carry a baby?
NCT ID NCT07230574
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether a woman's own immune cells, turned into decidual-like NK cells in a lab and then placed back into her uterus, can improve pregnancy chances. It includes 159 women with abnormal uterine NK cells and a history of reproductive failure. The main goal is to see if more women achieve an ongoing pregnancy (at least 12 weeks) after treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- autologous decidual-like NK cells
- What this could lead to
- If it works, this could offer a new treatment for women with recurrent miscarriage or unexplained infertility linked to abnormal uterine NK cells.
- What could go wrong
- This is an early phase 2 trial with only 159 participants, so results may not apply to everyone. The therapy is experimental and may not improve pregnancy rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ABORTION, MISSED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists hunt for genes that control puberty
- Which embryo is best? new study aims to boost IVF success
- Could a smartphone app replace hospital visits for Women's emergency aftercare?
- Aging clues in cells may unlock fertility secrets for women after failed IVF
- Progesterone after IUI: a simple step to more live births?
- New chip could pick healthier sperm for IVF